Epicore BioNetworks Inc. Announces ISO 9001:2008 Registration

CALGARY, May 7, 2012 /PRNewswire/ --

Epicore announces that its USA based business has achieved ISO 9001:2008 registration. ISO 9001:2008 is a quality system based on standards published by the International Organization for Standardization. Epicore's quality system was developed with the help of consultants, Change Management Consulting Inc., and was certified by Perry Johnson Registrars Inc., who is accredited by the American National Standards Institute and American Society for Quality Board (ANAB). The Epicore ISO 9001:2008 registration covers product development, manufacture and sales functions.

Since its inception, Epicore has maintained high quality standards. The recently achieved ISO 9001:2008 registration will help ensure all our company management systems deliver consistent quality and value to our customers and other stakeholders. In the interest of improved food safety, aquaculture producers increasingly are adopting ISO 9001:2008 and other quality systems. Quality registration is increasingly becoming a requirement to secure government approvals to import and sell aquaculture feeds and feed additives.

Epicore BioNetworks Inc. is a leading producer of environmental biotechnology and animal nutrition products. It manufactures in the USA and markets worldwide to a variety of industries to reduce environmental pollution and increase operational productivity.

Epicore BioNetworks Inc. is a public corporation with a registered office in Calgary, Alberta, Canada and with shares listed on the TSX Venture Exchange (symbol EBN). [Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.]

This press release contains forward-looking statements that involve significant risks and uncertainties. The actual results, performance or achievements of the company might differ materially from the results, performance or achievements of the company expressed or implied by such forward-looking statements. Such forward-looking statements include those relating to the ability of the company to ensure delivery of consistent quality and value to stakeholders. We can provide no assurance that this will occur. We are subject to various risks, including the costs of compliance, the risk that ISO 9001 will not guarantee a successful quality system and other risks inherent in the biotechnology industry.

For further information:

Please contact: Mr. William P. Long (Chief Executive Officer) USA. Tel: +1-609-267-9118, Email: Investors@EpicoreBioNetworks.com

(EBN.)